颅内动脉瘤市场Share, Size, Trends, Industry Analysis Report, By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others), By End-Use (Hospitals, Clinics, Others); By Regions; Segment Forecast, 2021 - 2028

报告摘要

这global intracranial aneurysm market was valued at USD 1.12 billion in 2020 and is expected to grow at a CAGR of 9.9% during the forecast period. An intracranial aneurysm is an expansion of the arteries present in the brain, resulting in blebbing, ballooning, and widening.

Intracranial aneurysm majorly occurs in the artery supplying oxygen to blood vessels of the brain. Smoking, drinking, injury to blood vessels, and genetic predisposition are largely responsible for the formation of a intracranial aneurysm. Current treatment methods include endovascular coiling, medical therapy, and surgical clipping.

了解有关此报告的更多信息：request for sample pages

Factors boosting the intracranial aneurysm market growth include the rising number of individuals suffering from cardiovascular diseases, faulty lifestyles, and growing patient choices towards minimally invasive surgeries. Faulty and busier lifestyles coupled with hypertension significantly increases the risk of developing such aneurysms.

目前，在过去几年中一直吸烟和饮酒的大部分群体具有较高的颅内动脉瘤的机会。例如，根据谁，2019年，大约11亿人患有高血压。此外，全球人口均比预期的速度较快，因此预计颅内装置的主要消费将在预测期内增长。

Industry Dynamics

Growth Drivers
An increasing number of individuals suffering from high blood pressure and hypertension is expected to be a prominent factor in the market. As per studies of the NCBI, the prevalence rate of intracranial aneurysms among old age people is rapidly rising. According to the WHO, in 2018, it was estimated that the old age population is projected to rise to 2 billion, by 2050. Hence, such a large population base is expected to be a key success driver in shaping the future of the market for intracranial aneurysm.

如今，由于其风险和并发症较小，患者之间的微创手术是越来越重要的。较好和较小的切口减少了术后疼痛，促进更快的恢复，从而导致其快速采用，并在市场参与者中引发了研发投资。大玩家正在投资很大程度上引入最小的侵入式设备。

例如,2019年12月,USFDA已批准the endovascular device, Woven EndoBridge (WEB) for the treatment of the most challenging intracranial aneurysm. WEB is the unique device that allows both flow diversion and aneurysm, a sphere of woven wires, appearing like a spring basket, inserted via a minimally invasive catheter threaded into the aneurysm.

WEB mimics the shape of an aneurysm, preventing blood flow, and allowing blood vessels to heal. The entire surgical procedure takes around 50 minutes, which is much lesser in comparison with traditional interventions. Apart from its ability to decrease procedure time, it reduces patient’s time under anesthesia, exposure to radiation and contrast media, and minimizing complications rate.

颅内动脉瘤市场Report Scope

该市场主要基于类型，最终用途和地区进行分段。

By Type	通过最终使用	按地区
Surgical Clipping 血管内卷积 流动分流器 Others	医院 Clinics Others	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

Insight by Type

基于类型，颅内动脉瘤市场被分为血管内卷曲，手术剪裁，流动分流器等。2020年，血管内卷曲持有最大的收入市场份额。这种分段市场增长归因于个人对血管内卷烟提供的微创手术和益处的日益偏好。与其他人相比，它可以在短暂的恢复时间内轻松地访问多个动脉瘤的椎骨基底区域。因此，预计这种益处将推动分部的增长前景。

这flow diverters预计市场部门将在研究期间注册最高增长率。在过去几年中，产品的一致发射促使采用流动分流器。例如，在2020年8月，基于U.S.的医疗设备制造商推出了其前64个有线超越进化流动分流器，专门设计用于重定向血液流动以促进动脉瘤的自我愈合。早些时候，2018年7月，Balt获得了丝绸Vista流动转移支架的批准，以治疗未破坏的动脉瘤。这些举措预计将来会有富有成效的结果。

Insight by End-Use

On the basis of end-use, the market is classified into hospitals, clinics, and others. In 2020, the hospital market segment is estimated to account for the largest share. Rapid uptake among hospitals is due to the increasing number of surgeries and the presence of funds to buy such market products. These devices not only simplify surgery procedures but also help to provide faster and accurate results. Moreover, these procedures are considered to be amongst the most complicated surgeries and also hospitals are equipped with post-operative complications.

地理概述

估计北美市场估计占全球市场的最大份额。负责此类增长的区域市场因素包括美国和加拿大颅内动脉瘤的患病率，增加高血压和中风发病率，迅速衰老。此外，该地区强大的医疗保健设施的存在也赞成其市场增长。betway体育亚洲版入口

根据神经干预印度的市场估计，在2017年，在美国，仅600万人患有未破裂的颅内动脉瘤。据报道，每年，美国大约是30,000人死于破裂的颅内动脉瘤。同样，根据加拿大脑动脉瘤基金会的估计，每年约2,800至3,500人患有颅内动脉瘤。

竞争洞察力

运营颅内动脉瘤市场的一些主要球员是微孔Inc.（Terumo Corporation），B. Braun，Stryker，Medtronic，Johnson和Johnson Services Inc.，MicroPort Scientific Corporation和Codman Neuro（Integra Lifesciences必威开户注册）。